Understanding TB-500 Peptide and Its Role in Regenerative Care TB-500 is a synthetic version of a peptide fragment related to thymosin beta-4, a naturally occurring protein involved in cellular processes
Athira Pharma's fosgonimeton (ATH-1017), part of the same HGF/c-Met program, failed the primary endpoint of its Phase 2/3 LIFT-AD Alzheimer's trial in September 2024
These peptides work by harnessing the body's own mechanisms to repair tissue, reduce inflammation, and boost recovery, offering promising benefits without relying on pharmaceuticals
In contrast, peptides such as BPC-157, Thymosin Beta-4 (TB-500), Epithalon, and GHK-Cu remain experimental, often falling into a regulatory gray area, especially when promoted as supplements online